GVK Bio Opens Clinical Pharmacology Unit in Ahmedabad

GVK Biosciences has commissioned a new clinical pharmacology unit (CPU) in Ahmedabad, India. The Ahmedabad CPU adds 110 beds to GVK BIO’s existing capacity of 144 beds. The new unit will conduct a variety of studies in healthy volunteers.

Ahmedabad was the most preferred and logical destination for expansion considering the volunteer pool accessibility and proximity to about 10 CROs and leading Pharma companies, according to a company statement. The CPU has three clinical wards and special housing facilities for female volunteers.

GVK BIO’s Clinical Pharmacology Unit (CPU) is a top service provider of bioequivalence studies to generic pharma companies globally. The CPU unit, operational from 2004 in Hyderabad, has undergone several international audits, inspections and has key accreditations to its credit including the USFDA, DCG(I), ANVISA (Brazil), AFSSAPS (France), WHO and the Ministry of Health, Turkey. In addition to the healthy volunteer population, the Ahmedabad facility gives access to diseased population in psychiatry, metabolism, cardiovascular and neurology.